Jonathan S. Yu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Jonathan S. Yu has a total of 86 co-authors. Here are the top co-authors by number of shared publications:
Joshua S. Dines
Sports Medicine Institute, Hospital for Special Surgery, NY, USA
4 shared publicationsPeter Sculco
Weill Cornell Medical College, New York, NY, USA; Hospital for Special Surgery, New York, NY, USA
4 shared publicationsAjay Premkumar
Emory University School of Medicine, Department of Orthopedic Surgery, Atlanta, GA
3 shared publications- Sridharan
Department of Orthopaedic Surgery, University of California, Los Angeles, 100 UCLA Medical Plaza, Los Angeles, CA 90095, USA
3 shared publications - Ajay Premkumar
Hospital for Special Surgery, New York, NY
2 shared publications Frank Petrigliano
Department of Orthopedic Surgery, University of California Los Angeles, Los Angeles, CA, USA
2 shared publications
Latest Publications
- Open Access
- 10 February 2026
- Published by Elsevier in JSES International
- Vol. 10 (3) , 101656
Implant prices and physician reimbursement have declined more than total costs and hospital payments in total shoulder arthroplasty
- 10 February 2026
- Published by Elsevier in JSES International
- Vol. 10 (3) , 101656
Open AccessImplant prices and physician reimbursement have declined more than total costs and hospital payments in total shoulder arthroplasty
- Open Access
- 1 February 2026
- Published by Wiley in Arthroscopy, Sports Medicine, and Rehabilitation
- Vol. 8 (1)
The United States Leads the Globe in Venture Capital Funding for Orthopaedic Surgery
Purpose: To characterize venture capital (VC) investments in orthopaedic surgery over the past 25 years to evaluate trends in global innovation. Methods: All VC investments related to orthopaedic surgery between January 2000 and December 2024 were retrospectively evaluated using the PitchBook database (PitchBook Platform, PitchBook Data. Seattle, WA). The headquarter location of each company was reviewed. The year of each investment deal and investment size (US dollars) were aggregated. Deals were also evaluated with respect to funding category (surgical devices, biotechnology, drug discovery, hospital management/technology, medical equipment). Descriptive statistics, compound annual growth rate, 2‐sample t‐ tests, and regression analysis were conducted. Results: A total of $9.7 billion (in 2025 USD) in VC funding was invested in orthopaedic surgery, consisting of 1506 distinct deals. VC funding has steadily increased since 2000, most notably between 2020 and 2024, with 49.8% (750) of deals ( P < .001) and 71% of total funding ($7.8 billion) ( P = .024). Privately held companies made 98% (1481) of deals. Surgical devices led VC investment with 34% (514) of deals totaling $3.5 billion, with biotechnology following with 30% (457) of deals for $3.3 billion. These 2 categories saw significantly more investments than the remaining categories ( P < .001). Orthopaedic companies physically based in the United States of America (USA) received the most funding (811 deals, $6.9 billion). China, Japan, the United Kingdom, Canada, and South Korea followed, though with significantly fewer investments than the USA ( P < .001). Conclusions: VC funding in orthopaedic surgery has steadily increased over the past 25 years, largely concentrated in the United States, with a dramatic increase in the past 5 years driven by interest in orthobiologic therapies and digital health. Clinical Relevance: VC investment trends in orthopaedic surgery appear to mirror many of the broader macroeconomic forces seen in the health care sector and have a direct impact on future development, innovation, and clinical practice within orthopaedic surgery.
- 1 February 2026
- Published by Wiley in Arthroscopy, Sports Medicine, and Rehabilitation
- Vol. 8 (1)
Open AccessThe United States Leads the Globe in Venture Capital Funding for Orthopaedic Surgery
Purpose: To characterize venture capital (VC) investments in orthopaedic surgery over the past 25 years to evaluate trends in global innovation. Methods: All VC investments related to orthopaedic surgery between January 2000 and December 2024 were retrospectively evaluated using the PitchBook database (PitchBook Platform, PitchBook Data. Seattle, WA). The headquarter location of each company was reviewed. The year of each investment deal and investment size (US dollars) were aggregated. Deals were also evaluated with respect to funding category (surgical devices, biotechnology, drug discovery, hospital management/technology, medical equipment). Descriptive statistics, compound annual growth rate, 2‐sample t‐ tests, and regression analysis were conducted. Results: A total of $9.7 billion (in 2025 USD) in VC funding was invested in orthopaedic surgery, consisting of 1506 distinct deals. VC funding has steadily increased since 2000, most notably between 2020 and 2024, with 49.8% (750) of deals ( P < .001) and 71% of total funding ($7.8 billion) ( P = .024). Privately held companies made 98% (1481) of deals. Surgical devices led VC investment with 34% (514) of deals totaling $3.5 billion, with biotechnology following with 30% (457) of deals for $3.3 billion. These 2 categories saw significantly more investments than the remaining categories ( P < .001). Orthopaedic companies physically based in the United States of America (USA) received the most funding (811 deals, $6.9 billion). China, Japan, the United Kingdom, Canada, and South Korea followed, though with significantly fewer investments than the USA ( P < .001). Conclusions: VC funding in orthopaedic surgery has steadily increased over the past 25 years, largely concentrated in the United States, with a dramatic increase in the past 5 years driven by interest in orthobiologic therapies and digital health. Clinical Relevance: VC investment trends in orthopaedic surgery appear to mirror many of the broader macroeconomic forces seen in the health care sector and have a direct impact on future development, innovation, and clinical practice within orthopaedic surgery.
- 7 January 2026
- Published by Elsevier in The Journal of Arthroplasty
- Vol. 41 (9) , 2599-2604
Implant Prices and Physician Reimbursement Have Declined More Than Total Costs and Hospital Payments in Total Joint Arthroplasty
- 7 January 2026
- Published by Elsevier in The Journal of Arthroplasty
- Vol. 41 (9) , 2599-2604
Implant Prices and Physician Reimbursement Have Declined More Than Total Costs and Hospital Payments in Total Joint Arthroplasty
- Open Access
- 15 May 2025
- Published by Elsevier in Journal of Orthopaedic Reports
- Vol. 5 (1)
Why do surgeons get sued after performing amputations? An analysis of malpractice litigation from 1983 to 2024
- 15 May 2025
- Published by Elsevier in Journal of Orthopaedic Reports
- Vol. 5 (1)
Open AccessWhy do surgeons get sued after performing amputations? An analysis of malpractice litigation from 1983 to 2024
- 29 June 2023
- Published by Wiley in Knee Surgery, Sports Traumatology, Arthroscopy
- Vol. 31 (11) , 4735-4740
High degree of alignment precision associated with total knee arthroplasty performed using a surgical robot or handheld navigation
Purpose: The purpose of this study was to compare the precision of bony resections during total knee arthroplasty (TKA) performed using different computer‐assisted technologies.Methods: Patients who underwent a primary TKA using an imageless accelerometer‐based handheld navigation system (KneeAlign2®, OrthAlign Inc.) or computed tomography‐based large‐console surgical robot (Mako®, Stryker Corp.) from 2017 to 2020 were retrospectively reviewed. Templated alignment targets and demographic data were collected. Coronal plane alignment of the femoral and tibial components and tibial slope were measured on postoperative radiographs. Patients with excessive flexion or rotation preventing accurate measurement were excluded.Results: A total of 240 patients who underwent TKA using either a handheld (n = 120) or robotic (n = 120) system were included. There were no statistically significant differences in age, sex, and BMI between groups. A small but statistically significant difference in the precision of the distal femoral resection was observed between the handheld and robotic cohorts (1.5° vs. 1.1° difference between templated and measured alignments, p = 0.024), though this is likely clinically insignificant. There were no significant differences in the precision of the tibial resection between the handheld and robotic groups (coronal plane 0.9° vs. 1.0°, n.s.; sagittal plane 1.2° vs. 1.1°, n.s.). There were no significant differences in the rate of overall precision between cohorts (n.s.).Conclusions: A high degree of component alignment precision was observed for both imageless handheld navigation and CT‐based robotic cohorts. Surgeons considering options for computer‐assisted TKA should take other important factors, including surgical principles, templating software, ligament balancing, intraoperative adjustability, equipment logistics, and cost, into account.Level of evidence: III.
- 29 June 2023
- Published by Wiley in Knee Surgery, Sports Traumatology, Arthroscopy
- Vol. 31 (11) , 4735-4740
High degree of alignment precision associated with total knee arthroplasty performed using a surgical robot or handheld navigation
Purpose: The purpose of this study was to compare the precision of bony resections during total knee arthroplasty (TKA) performed using different computer‐assisted technologies.Methods: Patients who underwent a primary TKA using an imageless accelerometer‐based handheld navigation system (KneeAlign2®, OrthAlign Inc.) or computed tomography‐based large‐console surgical robot (Mako®, Stryker Corp.) from 2017 to 2020 were retrospectively reviewed. Templated alignment targets and demographic data were collected. Coronal plane alignment of the femoral and tibial components and tibial slope were measured on postoperative radiographs. Patients with excessive flexion or rotation preventing accurate measurement were excluded.Results: A total of 240 patients who underwent TKA using either a handheld (n = 120) or robotic (n = 120) system were included. There were no statistically significant differences in age, sex, and BMI between groups. A small but statistically significant difference in the precision of the distal femoral resection was observed between the handheld and robotic cohorts (1.5° vs. 1.1° difference between templated and measured alignments, p = 0.024), though this is likely clinically insignificant. There were no significant differences in the precision of the tibial resection between the handheld and robotic groups (coronal plane 0.9° vs. 1.0°, n.s.; sagittal plane 1.2° vs. 1.1°, n.s.). There were no significant differences in the rate of overall precision between cohorts (n.s.).Conclusions: A high degree of component alignment precision was observed for both imageless handheld navigation and CT‐based robotic cohorts. Surgeons considering options for computer‐assisted TKA should take other important factors, including surgical principles, templating software, ligament balancing, intraoperative adjustability, equipment logistics, and cost, into account.Level of evidence: III.
- 23 May 2023
- Published by Elsevier in The Journal of Arthroplasty
- Vol. 38 (7) , S381-S388
Which Combination is the Best? A Comparison of the Predictive Potential of Serum Biomarker Combinations to Diagnose Periprosthetic Joint Infection
- 23 May 2023
- Published by Elsevier in The Journal of Arthroplasty
- Vol. 38 (7) , S381-S388
Which Combination is the Best? A Comparison of the Predictive Potential of Serum Biomarker Combinations to Diagnose Periprosthetic Joint Infection
- 1 May 2023
- Published by Human Kinetics in Journal of Sport Rehabilitation
- Vol. 32 (4) , 440-448
A Systematic Review of Lower-Body Kinematic and Strength Factors Associated With Pitch Velocity in Adult Baseball Pitchers
Context: Ball velocity for baseball pitchers is influenced by a multitude of factors along the kinetic chain. While a vast amount of data currently exist exploring lower-extremity kinematic and strength factors in baseball pitchers, no previous study has systematically reviewed the available literature. Objective: The aim of this systematic review was to perform a comprehensive assessment of the available literature investigating the association between lower-extremity kinematic and strength parameters and pitch velocity in adult pitchers. Evidence Acquisition: Cross-sectional studies that investigated the association between lower-body kinematic and strength factors and ball velocity in adult pitchers were selected. A methodological index for nonrandomized studies checklist was used to evaluate the quality of all included studies. Evidence Synthesis: Seventeen studies met the inclusion criteria comprising a total of 909 pitchers (65%, professional, 33% college, and 3% recreational). The most studied elements were hip strength and stride length. The mean methodological index for nonrandomized studies score was 11.75 of 16 (range = 10–14). Pitch velocity was found to be influenced by several lower-body kinematic and strength factors including the following: (1) hip range of motion and strength of muscles around the hip and pelvis, (2) alterations in stride length, (3) alterations in lead knee flexion/extension, and (4) several pelvic and trunk spatial relationships throughout the throwing phase. Conclusions: Based on this review, we conclude that hip strength is a well-established predictor of increased pitch velocity in adult pitchers. Further studies in adult pitchers are needed to elucidate the effect of stride length on pitch velocity given mixed results across multiple studies. This study can provide a basis for trainers and coaches to consider the importance of lower-extremity muscle strengthening as a means by which adult pitchers can improve pitching performance.
- 1 May 2023
- Published by Human Kinetics in Journal of Sport Rehabilitation
- Vol. 32 (4) , 440-448
A Systematic Review of Lower-Body Kinematic and Strength Factors Associated With Pitch Velocity in Adult Baseball Pitchers
Context: Ball velocity for baseball pitchers is influenced by a multitude of factors along the kinetic chain. While a vast amount of data currently exist exploring lower-extremity kinematic and strength factors in baseball pitchers, no previous study has systematically reviewed the available literature. Objective: The aim of this systematic review was to perform a comprehensive assessment of the available literature investigating the association between lower-extremity kinematic and strength parameters and pitch velocity in adult pitchers. Evidence Acquisition: Cross-sectional studies that investigated the association between lower-body kinematic and strength factors and ball velocity in adult pitchers were selected. A methodological index for nonrandomized studies checklist was used to evaluate the quality of all included studies. Evidence Synthesis: Seventeen studies met the inclusion criteria comprising a total of 909 pitchers (65%, professional, 33% college, and 3% recreational). The most studied elements were hip strength and stride length. The mean methodological index for nonrandomized studies score was 11.75 of 16 (range = 10–14). Pitch velocity was found to be influenced by several lower-body kinematic and strength factors including the following: (1) hip range of motion and strength of muscles around the hip and pelvis, (2) alterations in stride length, (3) alterations in lead knee flexion/extension, and (4) several pelvic and trunk spatial relationships throughout the throwing phase. Conclusions: Based on this review, we conclude that hip strength is a well-established predictor of increased pitch velocity in adult pitchers. Further studies in adult pitchers are needed to elucidate the effect of stride length on pitch velocity given mixed results across multiple studies. This study can provide a basis for trainers and coaches to consider the importance of lower-extremity muscle strengthening as a means by which adult pitchers can improve pitching performance.
- 1 March 2023
- Published by Elsevier in Journal of Shoulder and Elbow Surgery
- Vol. 32 (8) , 1609-1617
Pent-up demand for total shoulder arthroplasty prior to Medicare eligibility at age 65 years: evidence from a national patient database and national survey data
- 1 March 2023
- Published by Elsevier in Journal of Shoulder and Elbow Surgery
- Vol. 32 (8) , 1609-1617
Pent-up demand for total shoulder arthroplasty prior to Medicare eligibility at age 65 years: evidence from a national patient database and national survey data
- 20 February 2023
- Published by Wolters Kluwer Health in Current Orthopaedic Practice
- Vol. 34 (3) , 97-102
Did the centers for medicare & medicaid services’ 2018 policy change removing total knee arthroplasty from the inpatient-only list affect overall patient outcomes in the medicare population?
Background: The 2018 Centers for Medicare & Medicaid Services (CMS) removal of total knee arthroplasty (TKA) from the Inpatient-Only (IPO) list was accompanied by confusion, lack of central guidance on patient selection criteria, payor misinterpretation of the updated policy, and altered payor incentives. The purpose of this study was to assess how the CMS policy change affected overall patient outcomes in the Medicare population after TKA. Methods: Using the ACS-NSQIP database, patients 65 years and older who underwent primary, elective, unilateral TKA without any significant medical comorbidity were included. Complication rates before (2014-2017) and after (2018-2019) CMS removal of TKA from the IPO list were compared using interrupted time series analysis to gauge the impact of the policy shift. Results: A total 185,294 TKA cases were included in the analysis. Following the CMS removal of TKA from the IPO list in 2018, there were significant decreases in rates of any adverse event (RR 0.90, 95% CI 0.83-0.98, P=0.02), any minor adverse event (RR 0.84, 95% CI 0.73-0.97, P=0.02), and thromboembolic events (RR 0.76, 95% CI 0.64-0.89, PP=0.31), reoperation (RR 0.92, 95% CI 0.78-1.09, P=0.33), or any major adverse event (RR 0.92, 95% CI 0.83-1.01, P=0.07). Conclusions: Though the CMS removal of TKA from the IPO list in 2018 was accompanied by the emergence of key new issues, the policy change did not adversely affect 30-day postoperative outcomes in the Medicare TKA patient population. Level of Evidence: Level IV—retrospective cohort study.
- 20 February 2023
- Published by Wolters Kluwer Health in Current Orthopaedic Practice
- Vol. 34 (3) , 97-102
Did the centers for medicare & medicaid services’ 2018 policy change removing total knee arthroplasty from the inpatient-only list affect overall patient outcomes in the medicare population?
Background: The 2018 Centers for Medicare & Medicaid Services (CMS) removal of total knee arthroplasty (TKA) from the Inpatient-Only (IPO) list was accompanied by confusion, lack of central guidance on patient selection criteria, payor misinterpretation of the updated policy, and altered payor incentives. The purpose of this study was to assess how the CMS policy change affected overall patient outcomes in the Medicare population after TKA. Methods: Using the ACS-NSQIP database, patients 65 years and older who underwent primary, elective, unilateral TKA without any significant medical comorbidity were included. Complication rates before (2014-2017) and after (2018-2019) CMS removal of TKA from the IPO list were compared using interrupted time series analysis to gauge the impact of the policy shift. Results: A total 185,294 TKA cases were included in the analysis. Following the CMS removal of TKA from the IPO list in 2018, there were significant decreases in rates of any adverse event (RR 0.90, 95% CI 0.83-0.98, P=0.02), any minor adverse event (RR 0.84, 95% CI 0.73-0.97, P=0.02), and thromboembolic events (RR 0.76, 95% CI 0.64-0.89, PP=0.31), reoperation (RR 0.92, 95% CI 0.78-1.09, P=0.33), or any major adverse event (RR 0.92, 95% CI 0.83-1.01, P=0.07). Conclusions: Though the CMS removal of TKA from the IPO list in 2018 was accompanied by the emergence of key new issues, the policy change did not adversely affect 30-day postoperative outcomes in the Medicare TKA patient population. Level of Evidence: Level IV—retrospective cohort study.
- 1 November 2022
- Published by Elsevier in The Journal of Arthroplasty
- Vol. 38 (4) , 668-672
Reasons and Risk Factors for Failed Same-Day Discharge After Primary Total Knee Arthroplasty
- 1 November 2022
- Published by Elsevier in The Journal of Arthroplasty
- Vol. 38 (4) , 668-672
Reasons and Risk Factors for Failed Same-Day Discharge After Primary Total Knee Arthroplasty